Emerging research uncovers greater understanding of certain breast cancers
Published:
Tags:
WESTON, Fla. – An estimated 10% to 20% of breast cancers are known as “triple negative,” meaning they don’t respond to hormonal therapies and other medications.
While this can make triple negative breast cancer more deadly, Dr. Thomas Samuel, an oncologist with the Cleveland Clinic Weston, said a recent study found sub-types of the disease that respond differently to treatment.
“What this tells us is that if you have some of these certain sub-types, they may need less therapy than we would normally recommend. In other words, all triple negative breast cancers are not the same and they shouldn’t all be treated the same. There really should be a breakdown of what type of triple negative cancer it is and then tailor the treatment to that diagnosis,” he said.